Clinical Trials
INOVIO Expands Partnership with Advaccine to Conduct Global Phase 3 Efficacy Trial of COVID-19 DNA Vaccine Candidate
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases,...
Clinical Trials
Innovation Pharma Completes Enrollment in Phase 2 Clinical Trial for COVID-19
Innovation Pharmaceuticals, a clinical stage biopharmaceutical company, announced that it has achieved full patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 clinical trial of...
Clinical Trials
NRx Pharmaceuticals Announces Positive Results for ZYESAMI and Submits EUA Application to US FDA to Treat Critical COVID-19 in Patients
NRx Pharmaceuticals , a clinical stage pharmaceutical company, announced it has filed an application with U.S. FDA requesting Emergency Use Authorization (EUA) for ZYESAMI™ (Aviptadil-acetate),...
Clinical Trials
Moderna Reports Positive COVID-19 Vaccine Results in Adolescents
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Phase 2/3 study of its COVID-19 vaccine (mRNA-1273) in adolescents...
Clinical Trials
Bharat Biotechs Covaxin approved for phase 2/3 trials on children
The Drugs Controller General of India (DGCI) has approved Bharat Biotech's COVID-19 vaccine Covaxin for phase II/III clinical trial on those aged between two to...
Clinical Trials
INOVIO Announces Positive Data from Phase 2 Segment of Clinical Trial Evaluating INO-4800, its COVID-19 DNA Vaccine
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases,...
Clinical Trials
Cryoport and LabConnectPartner to Provide Support for Innovative Triumvira Cell and Gene Therapy Clinical Trial
LabConnect, Inc. and Cryoport, Inc. announced a partnership to provide comprehensive logistics support for an upcoming Phase I/II clinical trial sponsored by Triumvira Immunologics Inc.,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.